FindTrial
Sign In

Screening human embryonic aneuploidy by secreted proteomics for clinical application

Prediction of human embryonic chromosome ploidy by human embryonic secretory protein

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-16009244
Enrollment
Unknown
Registered
2016-09-22
Start date
2016-10-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Disease

Interventions

Chromosome ploidy group:No
Chromosome aneuploid group:No

Sponsors

Assisted reproduction center of NORTHWEST WOMEN'S AND CHILDREN'S HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female aged 35 to 40; 2. recurrent spontaneous abortion; 3. Repeated IVF-ET failure; 4. requiring for chromosome aneuploidy screening.

Exclusion criteria

Exclusion criteria: 1. One or both of the spouses of chromosome karyotype abnormalities; 2. Day 3 Embryo biopsy; 3. PGD cycle; 4. The abnormal chromosome genetic history; 5. The thawed embryos or blastocysts for PGS cycle.

Design outcomes

Primary

MeasureTime frame
protein mass spectrometry;—

Countries

China

Contacts

Public ContactShi Wenhao

NORTHWEST WOMEN'S AND CHILDREN'S HOSPITAL

swihao@yeah.net+86 15771798519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026